Stay updated on Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.

Latest updates to the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision history updated: added Revision: v3.4.2 and removed Revision: v3.4.1. This update is administrative and does not affect study details or results.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. This appears to be a minor maintenance update without altering study information.SummaryDifference0.0%

- Check28 days agoChange DetectedGlossary display is now shown and a new QC-related field ('Last Update Submitted that Met QC Criteria') plus a 'No FEAR Act Data' item and page revision indicator (v3.4.0) were introduced. The prior QC field ('Last Update Submitted that met QC Criteria'), the 'No FEAR Act data' item, and the older revision (v3.3.4) were removed.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision notes show a minor version update: v3.3.4 added and v3.3.3 removed, with no changes to the main study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedLocations were updated to reorganize and expand the list of study sites by country and region, with many locations added and previous location blocks removed; a Revision: v3.3.3 tag was added.SummaryDifference2%

- Check93 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no substantive changes to study details, eligibility, or results sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.